Semi-Annual Report
J.P. Morgan Exchange-Traded Funds
December 31, 2022  (Unaudited)
Fund
Ticker
Listing Exchange
JPMorgan ActiveBuilders U.S. Large Cap Equity ETF
JUSA
NYSE Arca
JPMorgan Active Growth ETF
JGRO
NYSE Arca
JPMorgan Active Value ETF
JAVA
NYSE Arca
JPMorgan Equity Premium Income ETF
JEPI
NYSE Arca
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
Nasdaq Stock Market® LLC

CONTENTS
 
 
1
2
3
3
6
9
12
15
18
37
44
46
56
57
61
Investments in a Fund are not deposits or obligations of, or guaranteed or endorsed by, any bank and are not insured or guaranteed by the FDIC, the Federal Reserve Board or any other government agency. You could lose money if you sell when a Fund’s share price is lower than when you invested.
Past performance is no guarantee of future performance. The general market views expressed in this report are opinions based on market and other conditions through the end of the reporting period and are subject to change without notice. These views are not intended to predict the future performance of a Fund or the securities markets.
Prospective investors should refer to the Funds’ prospectuses for a discussion of the Funds’ investment objectives, strategies and risks. Call J.P. Morgan Exchange-Traded Funds at (844) 457-6383 for a prospectus containing more complete information about a Fund, including management fees and other expenses. Please read it carefully before investing.
Shares are bought and sold throughout the day on an exchange at market price (not at net asset value) through a brokerage account, and are not individually subscribed and redeemed from a Fund. Shares may only be subscribed and redeemed directly from a Fund by Authorized Participants, in very large creation/redemption units. Brokerage commissions will reduce returns.

President's Letter
February 13, 2023 (Unaudited)
Dear Shareholder,
Financial markets have rebounded somewhat as the U.S. and other developed market economies have shown notable resilience in the face of higher inflation, rising interest rates and the ongoing war in Ukraine. While the factors that weighed on equity and bond markets in 2022 largely remain, there are signals that inflationary pressures may have peaked and the long-term economic outlook appears positive.

“Investors may face continued
economic and geopolitical challenges
in the year ahead. However, some of
the acute risks encountered in 2022
appear to have receded and last
year’s reset in asset prices may
provide attractive investment
opportunities.”
— Brian S. Shlissel

While U.S. economic growth was surprisingly strong in the closing months of 2022, with broad gains in employment and consumer spending in the final months of the year, the U.S. Federal Reserve’s efforts to counter inflationary pressure through sharply higher interest rates could slow economic momentum in the months ahead.
Corporate earnings have been squeezed by higher costs for materials and labor, while the strong U.S. dollar has hindered export revenues. However, the impact of higher prices and interest rates has not landed on all sectors of the economy evenly. Energy sector profits have soared over the past year, while earnings in housing and construction sectors have declined.
Across Europe, the war in Ukraine has driven up prices for energy, food and a range of other goods and has fueled negative consumer sentiment. The prolonged nature of the conflict and its potential to spread remain key concerns among policymakers, diplomats, military planners, economists and investors. It is worth noting that Europe’s largest industrialized nations in concert with the European Union have moved swiftly to secure alternatives to Russian sources of natural gas and petroleum, which has eased an energy crisis that began last year.
Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities. A long-term view and a properly diversified portfolio, in our opinion, remain key elements to a successful investment approach.
Our broad array of investment solutions seeks to provide investors with ability to build durable portfolios that can help them meet their financial goals.
Sincerely,
Brian S. Shlissel
President - J.P. Morgan Exchange-Traded Funds
J.P. Morgan Asset Management
1-844-4JPM-ETF or jpmorgan.com/etfs for more information
December 31, 2022
J.P. Morgan Exchange-Traded Funds
1

J.P. Morgan Exchange-Traded Funds
MARKET OVERVIEW
SIX MONTHS ENDED  December 31, 2022 (Unaudited)
Overall, leading U.S. equity indexes ended the period with positive returns, rebounding from a broad sell-off in August and September. Investors were largely focused on the pace and size of interest rate increases by the U.S. Federal Reserve (the “Fed”), while the highest inflation rate in 40 years, the war in Ukraine and pandemic-related disruptions in China weighed on global financial markets.    
During the second half of 2022, the Fed raised interest rates in July, September, November and December, following three increases in the first half of the year. Meanwhile, corporate earnings for the second and third quarters of 2022, generally were better than expected given a cooling economy and slower consumer spending. The U.S. unemployment rate remained historically low, hovering between 3.5% and 3.7% for the six-month period. 
Within U.S. equity markets, the energy sector outperformed amid constrained supply from Russia and Europe’s efforts to find alternative sources of petroleum and natural gas. The utilities sector also performed well as investors sought attractive dividend yields and companies less exposed to economic cycles. The real estate sector largely underperformed amid rising interest rates, while changing consumer habits and investor concerns over increased competition weighed on the communication services sector.  
Overall, mid cap growth stocks generated the highest U.S. equity returns, while large cap and mid cap value stocks outperformed small cap stocks and large cap growth stocks. For the six month period, S&P 500 Index returned 2.31%, the Russell 1000 Index returned 2.30%, the Russell Mid Cap Index returned 6.20% and the Russell 2000 Index returned 3.91%
 
2
J.P. Morgan Exchange-Traded Funds
December 31, 2022

JPMorgan ActiveBuilders U.S. Large Cap Equity ETF
FUND COMMENTARY
SIX MONTHS ENDED DECEMBER 31, 2022 (Unaudited)
REPORTING PERIOD RETURN:
 
Net Asset Value*
3.28%
Market Price**
3.45%
S&P 500 Index
2.31%
Net Assets as of 12/31/2022
$24,075,020
Fund Ticker
JUSA
INVESTMENT OBJECTIVE ***
The JPMorgan ActiveBuilders U.S. Large Cap Equity ETF (the “Fund”) seeks to provide long-term capital appreciation.
INVESTMENT APPROACH
The Fund invests primarily in equity securities of large, well-established companies located in the U.S. The Fund allocates to a variety of the adviser’s actively managed U.S. equity strategies, including style strategies and seeks to outperform the S&P 500 Index (the “Benchmark”) over time while maintaining similar risk characteristics.
WHAT WERE THE MAIN DRIVERS OF THE FUND’S PERFORMANCE?
For the six months ended December 31, 2022, the Fund outperformed the Benchmark.
The Fund’s security selection in the capital goods and health care equipment & services sectors was a leading contributor to performance relative to the Benchmark, while the Fund’s security selection in the banks sector and the media & entertainment sector was a leading detractor from relative performance.
Leading individual contributors to relative performance included the Fund’s overweight positions in Deere & Co., Lowe’s Cos. and AutoZone Inc. Shares of Deere, an agricultural equipment and machinery manufacturer, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022 and forecast higher sales and
earnings. Shares of Lowe’s, a home improvement retail chain, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022 and raised its earnings forecast. Shares of AutoZone, an automotive parts retail chain, rose after the company reported fiscal first quarter results that included better-than-expected earnings and revenue, and growth in same-store sales.
Leading individual detractors from relative performance included the Fund’s underweight positions in JPMorgan Chase & Co. and Netflix Inc., and its overweight position in Bristol-Myers Squibb Co. Shares of JPMorgan Chase, a banking and financial services company that the Fund is prohibited from holding because it is an affiliate, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022. Shares of Netflix, an entertainment content and services provider, rose amid improving subscriber numbers and positive investor response to the company’s advertising initiatives during the period. Shares of Bristol Myers Squibb, a pharmaceuticals developer, fell after the company reported third quarter 2022 sales were hurt by competition from generic drugs and unfavorable foreign exchange rates.
HOW WAS THE FUND POSITIONED?
During the period, the Fund’s largest overweight allocations relative to the Benchmark were to the health care equipment & services sector and the retailing sector and its largest underweight allocations were to the technology hardware &
equipment sector and software & services sector.
December 31, 2022
J.P. Morgan Exchange-Traded Funds
3

JPMorgan ActiveBuilders U.S. Large Cap Equity ETF
FUND COMMENTARY
SIX MONTHS ENDED DECEMBER 31, 2022 (Unaudited) (continued)

*
The return shown is based on net asset value and may differ from the return shown in the financial highlights, which reflects adjustments made to the net asset value in accordance with accounting principles generally accepted in the United States of America. The net asset value was $43.77 as of December 31, 2022.
**
Market price return was calculated assuming an initial investment made at the market price at the beginning of the reporting period, reinvestment of all dividends and distributions at market price during the period, and sale at the market price on the last day of the period. The price used to calculate the market price return was the closing price on the NYSE Arca. As of December 31, 2022, the closing price was $43.75.
***
The adviser seeks to achieve the Fund’s objective. There can be no guarantee it will be achieved.
TOP TEN HOLDINGS OF THE
PORTFOLIO AS OF December 31, 2022
PERCENT OF
TOTAL
INVESTMENTS
1.
Microsoft Corp.
6.0%
2.
Apple, Inc.
5.2
3.
AbbVie, Inc.
2.8
4.
UnitedHealth Group, Inc.
2.7
5.
Amazon.com, Inc.
2.3
6.
Alphabet, Inc., Class A
2.1
7.
ConocoPhillips
2.0
8.
Coca-Cola Co. (The)
1.7
9.
Deere & Co.
1.6
10.
NextEra Energy, Inc.
1.6
PORTFOLIO COMPOSITION
BY SECTOR AS OF December 31, 2022
PERCENT OF
TOTAL
INVESTMENTS
Information Technology
23.0%
Health Care
18.4
Financials
12.2
Consumer Discretionary
11.9
Industrials
9.9
Communication Services
5.7
Energy
5.5
Consumer Staples
4.7
Utilities
3.2
Materials
3.2
Real Estate
1.9
Short-Term Investments
0.4
4
J.P. Morgan Exchange-Traded Funds
December 31, 2022

AVERAGE ANNUAL TOTAL RETURNS AS OF December 31, 2022
 
INCEPTION DATE
SIX MONTHS*
1 YEAR
SINCE
INCEPTION
JPMorgan ActiveBuilders U.S. Large Cap Equity ETF
 
 
 
 
Net Asset Value
July 7, 2021
3.28%
(16.78)%
(6.00)%
Market Price
 
3.45
(16.89)
(6.02)

 
*
Not annualized.
LIFE OF FUND PERFORMANCE  (7/7/21 TO 12/31/22)
The performance quoted is past performance and is not a guarantee of future results. Exchange-traded funds  are subject to certain market risks. Investment returns and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance data shown. For up-to-date month-end performance information please call 1-844-457-6383. 
Fund commenced operations on July 7, 2021.
The graph illustrates comparative performance for $10,000 invested in shares of the JPMorgan ActiveBuilders U.S. Large Cap Equity ETF and the S&P 500 Index from July 7, 2021 to December 31, 2022. The performance of the Fund reflects the deduction of Fund expenses and assumes reinvestment of all dividends and capital gain distributions, if any. The performance of the S&P 500
Index does not reflect the deduction of expenses associated with an exchange-traded fund and approximates the minimum possible dividend reinvestment of the securities included in the Index, if applicable. The S&P 500 Index is an unmanaged index generally representative of the performance of large companies in the U.S. stock market. Investors cannot invest directly in an index.
Performance shown in this section does not reflect the deduction of taxes that a shareholder may pay on Fund distributions or on gains resulting from redemption or sale of Fund shares.
The returns shown are based on net asset values calculated for shareholder transactions and may differ from the returns shown in the financial highlights, which reflect adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
December 31, 2022
J.P. Morgan Exchange-Traded Funds
5

JPMorgan Active Growth ETF
FUND COMMENTARY
FOR THE PERIOD AUGUST 8, 2022 (FUND INCEPTION) THROUGH DECEMBER 31, 2022 (Unaudited)
REPORTING PERIOD RETURN:
 
Net Asset Value*
(10.91)%
Market Price**
(10.91)%
Russell 1000 Growth Index
(13.13)%
Net Assets as of 12/31/2022
$139,938,629
Fund Ticker
JGRO
INVESTMENT OBJECTIVE ***
The JPMorgan Active Growth ETF (the “Fund”) seeks to provide long-term capital appreciation.
INVESTMENT APPROACH
The Fund invests primarily in equity securities of U.S. large-capitalization companies, but the adviser has discretion to invest in securities across the whole market capitalization spectrum, including securities of mid-capitalization and small-capitalization companies. In implementing its main strategies, the Fund invests primarily in common stocks of companies that the adviser believes have strong earnings growth potential.
HOW DID THE FUND PERFORM?
For the period from inception on August 8, 2022 to December 31, 2022, the Fund had a negative absolute return and outperformed the Russell 1000 Growth Index (the “Benchmark).
The Fund’s overweight position in the health care sector and its underweight position in the consumer discretionary sector were leading contributors to performance relative to the Benchmark, while the Fund’s security selection in the technology and financials sectors was a leading detractor from relative performance. 
Leading individual contributors to relative performance included the Fund’s overweight positions in Deere & Co. and Regeneron Pharmaceuticals Inc., and its underweight position in Amazon.com Inc. Shares of Deere, an agricultural equipment and machinery manufacturer, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022 and forecast higher sales and earnings. Shares
of Regeneron Pharmaceuticals, a drug development company, rose after the company reported positive clinical results for several of its drug candidates. Shares of Amazon.com, an internet retailer and services provider, fell amid a broad decline in large capitalization technology companies.
Leading individual detractors from relative performance included the Fund’s overweight positions in SVB Financial Group and Catalent Inc., and its underweight position in Visa Inc. 
Shares of SVB Financial Group, a regional banking and financial services company, fell after the company reported lower-than-expected revenue for the third quarter of 2022 and amid investor concern about the company’s exposure to the information technology sector. Shares of Catalent, a pharmaceuticals maker, fell after the company reported lower-than-expected earnings and revenue for the third quarter of 2022 and lowered its forecast for the full year. Shares of Visa, a credit card and financial transactions processor, rose after the company reported better-than-expected earnings and revenue for its fiscal fourth quarter, increased its quarterly dividend by 20% and unveiled a $12 billion share repurchase plan. 
HOW WAS THE FUND POSITIONED?
During the period, the Fund’s portfolio managers employed a bottom-up approach to stock selection, based on company fundamentals, quantitative screening and proprietary fundamental analysis. As a result of this process, the Fund’s largest sector allocations were to the technology and health care sectors and it had no allocations to the real estate and utilities sectors.
6
J.P. Morgan Exchange-Traded Funds
December 31, 2022


*
The return shown is based on net asset value and may differ from the return shown in the financial highlights, which reflects adjustments made to the net asset value in accordance with accounting principles generally accepted in the United States of America. The net asset value was $44.43 as of December 31, 2022.
**
Market price return was calculated assuming an initial investment made at the inception date net asset value, reinvestment of all dividends and distributions at market price during the period, and sale at the market price on the last day of the period. The price used to calculate the market price return was the closing price on the NYSE Arca. As of December 31, 2022, the closing price was $44.43.
***
The adviser seeks to achieve the Fund’s objective. There can be no guarantee it will be achieved.
TOP TEN HOLDINGS OF THE
PORTFOLIO AS OF December 31, 2022
PERCENT OF
TOTAL
INVESTMENTS
1.
Apple, Inc.
7.9%
2.
Microsoft Corp.
7.8
3.
Alphabet, Inc., Class C
3.6
4.
Amazon.com, Inc.
3.3
5.
UnitedHealth Group, Inc.
2.7
6.
Deere & Co.
2.6
7.
Regeneron Pharmaceuticals, Inc.
2.3
8.
Eli Lilly & Co.
2.2
9.
Charles Schwab Corp. (The)
2.0
10.
McKesson Corp.
1.9
PORTFOLIO COMPOSITION
BY SECTOR AS OF December 31, 2022
PERCENT OF
TOTAL
INVESTMENTS
Information Technology
33.5%
Health Care
21.5
Consumer Discretionary
13.1
Industrials
9.5
Financials
6.0
Communication Services
4.4
Energy
3.3
Consumer Staples
3.1
Materials
1.5
Short-Term Investments
4.1
December 31, 2022
J.P. Morgan Exchange-Traded Funds
7

JPMorgan Active Growth ETF
FUND COMMENTARY
FOR THE PERIOD AUGUST 8, 2022 (FUND INCEPTION) THROUGH DECEMBER 31, 2022 (Unaudited) (continued)
TOTAL RETURNS AS OF December 31, 2022
 
INCEPTION DATE
CUMULATIVE SINCE
INCEPTION
JPMorgan Active Growth ETF
 
 
Net Asset Value
August 8, 2022
(10.91)%
Market Price
 
(10.91)
LIFE OF FUND PERFORMANCE  (8/8/22 TO 12/31/22)
The performance quoted is past performance and is not a guarantee of future results. Exchange-traded funds  are subject to certain market risks. Investment returns and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance data shown. For up-to-date month-end performance information please call 1-844-457-6383. 
Fund commenced operations on August 8, 2022.
The graph illustrates comparative performance for $10,000 invested in shares of the JPMorgan Active Growth ETF and the Russell 1000 Growth Index from August 8, 2022 to December 31, 2022. The performance of the Fund reflects the deduction of Fund expenses and assumes reinvestment of all dividends and capital gain distributions, if any. The Russell 1000 Growth Index does not reflect
the deduction of expenses associated with an exchange-traded fund and has been adjusted to reflect reinvestment of all dividends and capital gain distributions of the securities included in the Index, if applicable. The Russell 1000 Growth Index is an unmanaged index measuring the performance of those Russell 1000 companies with higher price-to-book ratios and higher forecasted growth values. Investors cannot invest directly in an index.
Performance shown in this section does not reflect the deduction of taxes that a shareholder may pay on Fund distributions or on gains resulting from redemption or sale of Fund shares.
The returns shown are based on net asset values calculated for shareholder transactions and may differ from the returns shown in the financial highlights, which reflect adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
8
J.P. Morgan Exchange-Traded Funds
December 31, 2022

JPMorgan Active Value ETF
FUND COMMENTARY
SIX MONTHS ENDED DECEMBER 31, 2022 (Unaudited)
REPORTING PERIOD RETURN:
 
Net Asset Value*
7.94%
Market Price**
8.12%
Russell 1000 Value Index
6.11%
Net Assets as of 12/31/2022
$302,386,680
Fund Ticker
JAVA
INVESTMENT OBJECTIVE***
The JPMorgan Active Value ETF (the “Fund”) seeks to provide long-term capital appreciation.
INVESTMENT APPROACH
The Fund invests primarily in large- and mid-cap equity securities that the adviser believes are attractively valued given their growth potential over a long-term time horizon. The Fund employs a bottom-up approach to stock selection, constructing a portfolio based on company fundamentals, quantitative screening and proprietary fundamental analysis.
WHAT WERE THE MAIN DRIVERS OF THE FUND’S PERFORMANCE?
For the six months ended December 31, 2022, the Fund outperformed the Russell 1000 Value Index (the “Benchmark”).
The Fund’s security selection in the consumer discretionary sector and its underweight position in the communication services sector were leading contributors to performance relative to the Benchmark, while the Fund’s security selection in the financials and utilities sectors was a leading detractor from relative performance.
Leading individual contributors to relative performance included the Fund’s underweight position in Intel Corp., it’s overweight position in Cardinal Health Inc. and its out-of-Benchmark position in TJX Cos. Shares of Intel, a semiconductor manufacturer not held in the Fund, fell with the broader semiconductor sub-sector amid lower industry growth forecasts and changes in global technology supply chains. Shares of Cardinal Health, a pharmaceuticals and health care products distributor, rose after the company reported
better-than-expected earnings and revenue for its fiscal first quarter. Shares of TJX, an operator of discount retail apparel and home products chains, rose after reporting consecutive quarters of better-than-expected earnings and amid investor expectations that U.S. consumers would migrate toward lower priced retailers.
Leading individual detractors from relative performance included the Fund’s underweight position in JPMorgan Chase & Co., and its overweight positions in Bristol-Myers Squibb Co. and Fidelity National Information Services Inc. Shares of JPMorgan Chase, a banking and financial services company that the Fund is prohibited from holding because it is an affiliate, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022. Shares of Bristol-Myers Squibb, a pharmaceuticals developer, fell after the company reported third quarter 2022 sales were hurt by competition from generic drugs and unfavorable foreign exchange rates. Shares of Fidelity National Information Services, a financial services technology provider, fell after the company reported lower-than-expected earnings and revenue for the third quarter of 2022 and lowered its earnings forecast for the full year 2022.
HOW WAS THE FUND POSITIONED?
During the period, the Fund’s portfolio managers employed a bottom-up approach to stock selection, based on company fundamentals, quantitative screening and proprietary fundamental analysis. As a result of this process, the Fund’s largest sector allocations were to the financials and health care sectors and its smallest allocations were to the real estate and
utilities sectors.
December 31, 2022
J.P. Morgan Exchange-Traded Funds
9

JPMorgan Active Value ETF
FUND COMMENTARY
SIX MONTHS ENDED DECEMBER 31, 2022 (Unaudited) (continued)

*
The return shown is based on net asset value and may differ from the return shown in the financial highlights, which reflects adjustments made to the net asset value in accordance with accounting principles generally accepted in the United States of America. The net asset value was $51.25 as of December 31, 2022.
**
Market price return was calculated assuming an initial investment made at the market price at the beginning of the reporting period, reinvestment of all dividends and distributions at market price during the period, and sale at the market price on the last day of the period. The price used to calculate the market price return was the closing price on the NYSE Arca. As of December 31, 2022, the closing price was $51.23.
***
The adviser seeks to achieve the Fund’s objective. There can be no guarantee it will be achieved.
TOP TEN HOLDINGS OF THE
PORTFOLIO AS OF December 31, 2022
PERCENT OF
TOTAL
INVESTMENTS
1.
Bristol-Myers Squibb Co.
2.9%
2.
Wells Fargo & Co.
2.7
3.
Exxon Mobil Corp.
2.5
4.
Berkshire Hathaway, Inc., Class B
2.4
5.
Raytheon Technologies Corp.
2.0
6.
AbbVie, Inc.
2.0
7.
Chevron Corp.
1.9
8.
Bank of America Corp.
1.9
9.
Charter Communications, Inc., Class A
1.4
10.
ConocoPhillips
1.4
PORTFOLIO COMPOSITION BY SECTOR
AS OF December 31, 2022
PERCENT OF
TOTAL
INVESTMENTS
Financials
21.1%
Health Care
17.9
Industrials
12.2
Energy
9.2
Consumer Discretionary
7.1
Consumer Staples
6.7
Communication Services
5.5
Materials
5.2
Information Technology
5.1
Utilities
4.7
Real Estate
3.0
Short-Term Investments
2.3
10
J.P. Morgan Exchange-Traded Funds
December 31, 2022

AVERAGE ANNUAL TOTAL RETURNS AS OF December 31, 2022
 
INCEPTION DATE
SIX MONTHS*
1 YEAR
SINCE
INCEPTION
JPMorgan Active Value ETF
 
 
 
 
Net Asset Value
October 4, 2021
7.94%
(0.78)%
4.32%
Market Price
 
8.12
(0.88)
4.28

 
*
Not annualized.
LIFE OF FUND PERFORMANCE  (10/4/21 TO 12/31/22)
The performance quoted is past performance and is not a guarantee of future results. Exchange-traded funds  are subject to certain market risks. Investment returns and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance data shown. For up-to-date month-end performance information please call 1-844-457-6383. 
Fund commenced operations on October 4, 2021.
The graph illustrates comparative performance for $10,000 invested in shares of the JPMorgan Active Value ETF and the Russell 1000 Value Index from October 4, 2021 to December 31, 2022. The performance of the Fund reflects the deduction of Fund expenses and assumes reinvestment of all dividends and capital gain distributions, if any. The Russell 1000 Value Index does not reflect
the deduction of expenses associated with an exchange-traded fund and has been adjusted to reflect reinvestment of all dividends and capital gain distributions of the securities included in the Index, if applicable. The Russell 1000 Value Index is an unmanaged index measuring the performance of those Russell 1000 companies with lower price to-book ratios and lower forecasted growth values. Investors cannot invest directly in an index.
Performance shown in this section does not reflect the deduction of taxes that a shareholder may pay on Fund distributions or on gains resulting from redemption or sale of Fund shares.
The returns shown are based on net asset values calculated for shareholder transactions and may differ from the returns shown in the financial highlights, which reflect adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
December 31, 2022
J.P. Morgan Exchange-Traded Funds
11

JPMorgan Equity Premium Income ETF
FUND COMMENTARY
SIX MONTHS ENDED  December 31, 2022 (Unaudited)
REPORTING PERIOD RETURN:
 
Net Asset Value*
5.48%
Market Price**
5.56%
S&P 500 Index
2.31%
ICE BofAML 3-Month US Treasury Bill Index
1.32%
Net Assets as of 12/31/2022
$17,485,138,199
Fund Ticker
JEPI
INVESTMENT OBJECTIVE***
The JPMorgan Equity Premium Income ETF (the “Fund”) seeks current income while maintaining prospects for capital appreciation.
INVESTMENT APPROACH
The Fund seeks to generate income through a combination of options-based equity-linked notes and investing in a portfolio of U.S. large and mid cap stocks, comprised significantly of those includes in the S&P 500 Index (the “Benchmark”), seeking to provide monthly distributions at a relatively stable level. The Fund seeks to deliver a significant portion of the returns associated with the Benchmark, while exposing investors to lower volatility than the Benchmark and also providing incremental income. The Fund uses a proprietary research process designed to identify over- and undervalued stocks with attractive risk/return characteristics.
WHAT WERE THE MAIN DRIVERS OF THE FUND’S PERFORMANCE?
The Fund outperformed the both S&P 500 Index (the “Benchmark”) and the ICE BofAML 3-Month US Treasury Bill Index for the six months ended December 30, 2022. The Fund captured 238% of the Benchmark’s total return with about 61% of the Benchmark’s volatility during the reporting period, resulting in distributed income of $3.95 per share.
During the period, the Fund benefitted from increased volatility in financial markets and interest rates. The Fund’s underweight position in the information technology sector and its overweight positions in defensive sectors, including utilities and consumer staples, also contributed to performance amid a broad sell-off in the information technology sector during the period. The Benchmark rebounded somewhat in the fourth quarter of 2022 and the Fund’s use of call options (within the equity-linked note structure) on a rolling weekly basis allowed the Fund to further benefit from rising equity prices.
The Fund’s security selection in the consumer discretionary and information technology sectors was a leading contributor to performance relative to the Benchmark, while the Fund’s underweight position in the energy sector and its security
selection in the utilities sector were leading detractors from relative performance.
Leading individual contributors to relative performance included the Fund’s overweight positions in O’Reilly Automotive Inc. and Lowe’s Cos., and its underweight position in Amazon.com Inc. Shares of O’Reilly Automotive, an auto parts retailer, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022. Shares of Lowe’s, a home improvement retail chain, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022 and raised its earnings forecast. Shares of Amazon.com, an internet retailer and services provider, fell amid a broad decline in large capitalization technology companies. 
Leading individual detractors from relative performance included the Fund’s out-of-Benchmark position in TC Energy Inc. and its overweight positions in Exelon Corp. and Bristol-Myers Squibb Co. Shares of TC Energy, an oil and natural gas storage and pipelines operator, fell after the company shut down its Keystone Pipeline System following a leak an estimate half-million gallons of crude oil. Shares of Exelon, an electric utility, fell after the company reported lower-than-expected earnings for the second quarter of 2022 and investor concerns over winter storm damage. Shares of Bristol Myers Squibb, a pharmaceuticals developer, fell after the company reported third quarter 2022 sales were hurt by competition from generic drugs and unfavorable foreign exchange rates. 
HOW WAS THE FUND POSITIONED?
During the reporting period, the Fund’s portfolio managers maintained a defensive equity portfolio, investing primarily in common stocks of large cap U.S. companies, with reduced volatility compared with the Benchmark, while using options-based equity-linked notes in a consistent and disciplined manner. The combination of the diversified portfolio of equity securities and income from options-based equity-linked notes provided the Fund with returns associated with equity market investments, less risk compared with the
equity market, and a stream of distributable monthly income.
12
J.P. Morgan Exchange-Traded Funds
December 31, 2022


*
The return shown is based on net asset value and may differ from the return shown in the financial highlights, which reflects adjustments made to the net asset value in accordance with accounting principles generally accepted in the United States of America. The net asset value was $54.45 as of December 31, 2022.
**
Market price return was calculated assuming an initial investment made at the market price at the beginning of the reporting period, reinvestment of all dividends and distributions at market price during the period, and sale at the market price on the last day of the period. The price used to calculate the market price return was the closing price on the NYSE Arca. As of December 31, 2022, the closing price was $54.49.
***
The adviser seeks to achieve the Fund’s objective. There can be no guarantee it will be achieved.
****
Equity-Linked Notes that are linked to the S&P 500 Index.
TOP TEN HOLDINGS OF THE
PORTFOLIO AS OF December 31, 2022
PERCENT OF
TOTAL
INVESTMENTS
1.
AbbVie, Inc.
1.6%
2.
Progressive Corp. (The)
1.6
3.
Exxon Mobil Corp.
1.6
4.
UnitedHealth Group, Inc.
1.5
5.
Coca-Cola Co. (The)
1.5
6.
Hershey Co. (The)
1.5
7.
PepsiCo, Inc.
1.5
8.
Honeywell International, Inc.
1.4
9.
Bristol-Myers Squibb Co.
1.4
10.
Eli Lilly & Co.
1.4
PORTFOLIO COMPOSITION BY SECTOR
AS OF December 31, 2022
PERCENT OF
TOTAL
INVESTMENTS
Industrials
12.4%
Health Care
12.3
Consumer Staples
11.6
Information Technology
10.8
Financials
10.3
Utilities
7.8
Consumer Discretionary
5.6
Communication Services
3.7
Materials
3.3
Energy
2.8
Real Estate
2.6
Other****
15.3
Short-Term Investments
1.5
December 31, 2022
J.P. Morgan Exchange-Traded Funds
13

JPMorgan Equity Premium Income ETF
FUND COMMENTARY
SIX MONTHS ENDED  December 31, 2022 (Unaudited) (continued)
AVERAGE ANNUAL TOTAL RETURNS AS OF December 31, 2022
 
INCEPTION DATE
SIX MONTHS*
1 YEAR
SINCE
INCEPTION
JPMorgan Equity Premium Income ETF
 
 
 
 
Net Asset Value
May 20, 2020
5.48%
(3.54)%
13.34%
Market Price
 
5.56
(3.52)
13.36

 
*
Not annualized.
LIFE OF FUND PERFORMANCE  (5/20/20 TO 12/31/22)
The performance quoted is past performance and is not a guarantee of future results. Exchange-traded funds  are subject to certain market risks. Investment returns and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance data shown. For up-to-date month-end performance information please call 1-844-457-6383. 
Fund commenced operations on May 20, 2020.
The graph illustrates comparative performance for $10,000 invested in shares of the JPMorgan Equity Premium Income ETF, the S&P 500 Index and the ICE BofAML 3-Month US Treasury Bill Index from May 20, 2020 to December 31, 2022. The performance of the Fund reflects the deduction of Fund expenses and assumes reinvestment of all dividends and capital gain distributions, if any. The performance of the S&P 500 Index and the ICE BofAML 3-Month US Treasury Bill Index does not reflect the deduction of expenses associated with an exchange-traded fund and approximates the minimum possible dividend
reinvestment of the securities included in the benchmarks, if applicable. The S&P 500 Index is an unmanaged index generally representative of the performance of large companies in the U.S. stock market. The ICE BofAML 3-Month US Treasury Bill Index is comprised of a single issue purchased at the beginning of the month and held for a full month. Each month the ICE BofAML 3-Month US Treasury Bill Index is rebalanced and the issue selected is the outstanding Treasury Bill that matures closest to, but not beyond, 3 months from the rebalancing date. Investors cannot invest directly in an index.
Performance shown in this section does not reflect the deduction of taxes that a shareholder may pay on Fund distributions or on gains resulting from redemption or sale of Fund shares.
The returns shown are based on net asset values calculated for shareholder transactions and may differ from the returns shown in the financial highlights, which reflect adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
14
J.P. Morgan Exchange-Traded Funds
December 31, 2022

JPMorgan Nasdaq Equity Premium Income ETF
FUND COMMENTARY
SIX MONTHS ENDED DECEMBER 31, 2022 (Unaudited)
REPORTING PERIOD RETURN:
 
Net Asset Value*
(2.96)%
Market Price**
(3.51)%
Nasdaq-100 Index®
(4.46)%
ICE BofAML 3-Month US Treasury Bill Index
1.32%
Net Assets as of 12/31/2022
$1,004,291,637
Fund Ticker
JEPQ
INVESTMENT OBJECTIVE***
The JPMorgan Nasdaq Equity Premium Income ETF (the “Fund”) seeks current income while maintaining prospects for capital appreciation.
INVESTMENT APPROACH
The Fund seeks to generate income through a combination of options-based equity-linked notes and investing in a portfolio of U.S. large cap and mid cap growth stocks comprised significantly of those included in the Nasdaq-100 Index (the “Benchmark”), seeking to provide monthly distributions at a relatively stable level. The Fund seeks to deliver a significant portion of the returns associated with the Benchmark, while exposing investors to lower volatility than the Benchmark and also providing incremental income. The Fund’s equity portfolio follows a proprietary data science driven investment approach designed to construct a portfolio that maximizes risk-adjusted expected returns.
WHAT WERE THE MAIN DRIVERS OF THE FUND’S PERFORMANCE?
The Fund outperformed the Benchmark and underperformed the ICE BofAML 3-Month U.S. Treasury Bill Index for the six months ended December 31, 2022. The Fund captured 66% of the Benchmark’s total return with about 75% of the Benchmark’s volatility during the reporting period, resulting in distributed income of $3.48 per share. 
The Fund’s security selection in the information technology and consumer discretionary sectors was a contributor to performance relative to the Benchmark, while the Fund’s security selection in the health care and communications sectors was a leading detractor from relative performance. 
Leading individual contributors to relative performance included the Fund’s out-of-Benchmark positions in Deere & Co. and Eaton Corp., and its overweight position in DexCom Inc. Shares of Deere, an agricultural equipment and machinery
manufacturer, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022 and forecast higher sales and earnings. Shares of Eaton, a manufacturer of electrical components and equipment, rose after the company reported better-than-expected earnings for the third quarter of 2022. Shares of DexCom, a manufacturer of diabetes monitoring devices, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022 and forecast revenue growth for the full year 2022.
Leading individual detractors from relative performance included the Portfolio’s underweight positions in Gilead Sciences Inc., Starbucks Corp. and Ross Stores Inc. Shares of Gilead Sciences, a pharmaceuticals developer not held in the Fund, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022 and raised its forecast for the full year. Shares of Starbucks, a beverages and food retailer not held in the Fund, rose later in the period after the company reported better-than-expected earnings and revenue for its fiscal fourth quarter, as well as growth in comparable store sales. Shares of Ross Stores, a discount apparel retailer not held in the Fund, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022.
HOW WAS THE FUND POSITIONED?
During the period, the Fund’s portfolio managers employed a proprietary research process designed to identify what they believed were overvalued and undervalued stocks with attractive risk/return characteristics. The combination of the portfolio of equity securities and income from options-based equity-linked notes provided the Fund with a portion of the returns associated with equity market investments, less risk compared with the equity market, and a stream of distributable
monthly income.
December 31, 2022
J.P. Morgan Exchange-Traded Funds
15

JPMorgan Nasdaq Equity Premium Income ETF
FUND COMMENTARY
SIX MONTHS ENDED DECEMBER 31, 2022 (Unaudited) (continued)

*
The return shown is based on net asset value and may differ from the return shown in the financial highlights, which reflects adjustments made to the net asset value in accordance with accounting principles generally accepted in the United States of America. The net asset value was $40.78 as of December 31, 2022.
**
Market price return was calculated assuming an initial investment made at the market price at the beginning of the reporting period, reinvestment of all dividends and distributions at market price during the period, and sale at the market price on the last day of the period. The price used to calculate the market price return was the closing price on the Nasdaq Stock Market® LLC. As of December 31, 2022, the closing price was $40.80.
***
The adviser seeks to achieve the Fund’s objective. There can be no guarantee it will be achieved.
****
Equity-Linked Notes that are linked to the Nasdaq-100 Index.
ELN
Equity-Linked Note
TOP TEN HOLDINGS OF THE
PORTFOLIO AS OF December 31, 2022
PERCENT OF
TOTAL
INVESTMENTS
1.
Microsoft Corp.
10.5%
2.
Apple, Inc.
8.8
3.
Alphabet, Inc., Class C
6.6
4.
Amazon.com, Inc.
5.0
5.
UBS AG, ELN, 97.50%, 2/7/2023, (linked
to Nasdaq-100 Index) (Switzerland)
4.6
6.
Citigroup Global Markets Holdings, Inc.,
ELN, 103.55%, 1/31/2023, (linked to
Nasdaq-100 Index)
4.1
7.
BofA Finance LLC, ELN, 91.38%,
1/10/2023, (linked to Nasdaq-100
Index)
3.5
8.
BNP Paribas, ELN, 92.00%, 1/24/2023,
(linked to Nasdaq-100 Index)
3.0
9.
NVIDIA Corp.
2.4
10.
Tesla, Inc.
2.1
PORTFOLIO COMPOSITION BY SECTOR
AS OF December 31, 2022
PERCENT OF
TOTAL
INVESTMENTS
Information Technology
39.4%
Communication Services
12.3
Consumer Discretionary
11.6
Health Care
6.2
Consumer Staples
5.3
Industrials
3.7
Utilities
1.6
Real Estate
0.4
Energy
0.4
Other****
17.3
Short-Term Investments
1.8
16
J.P. Morgan Exchange-Traded Funds
December 31, 2022

TOTAL RETURNS AS OF December 31, 2022
 
INCEPTION DATE
SIX MONTHS*
SINCE
INCEPTION
JPMorgan Nasdaq Equity Premium Income ETF
 
 
 
Net Asset Value
May 3, 2022
(2.96)%
(11.04)%
Market Price
 
(3.51)
(11.01)

 
*
Not annualized.
LIFE OF FUND PERFORMANCE  (5/3/22 TO 12/31/22)
The performance quoted is past performance and is not a guarantee of future results. Exchange-traded funds  are subject to certain market risks. Investment returns and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance data shown. For up-to-date month-end performance information please call 1-844-457-6383. 
Fund commenced operations on May 3, 2022.
The graph illustrates comparative performance for $10,000 invested in shares of the JPMorgan Nasdaq Equity Premium Income ETF, the Nasdaq-100 Index and the ICE BofAML 3-Month US Treasury Bill Index from May 3, 2022 to December 31, 2022. The performance of the Fund reflects the deduction of Fund expenses and assumes reinvestment of all dividends and capital gain distributions, if any. The performance of the Nasdaq-100 Index and the ICE BofAML 3-Month US Treasury Bill Index does not reflect the deduction of expenses associated with an exchange-traded fund and approximates the minimum possible dividend reinvestment of the securities included in the benchmarks, if applicable. The Nasdaq-100 Index includes 100 of the largest domestic and international non-financial companies listed on The Nasdaq Stock Market based on market capitalization. The Index reflects companies across major industry groups including computer hardware and software, telecommunications, retail/wholesale trade and biotechnology. It does not
contain securities of financial companies including investment companies. The ICE BofAML 3-Month US Treasury Bill Index is comprised of a single issue purchased at the beginning of the month and held for a full month. Each month the ICE BofAML 3-Month US Treasury Bill Index is rebalanced and the issue selected is the outstanding Treasury Bill that matures closest to, but not beyond, 3 months from the rebalancing date. Investors cannot invest directly in an index.
Performance shown in this section does not reflect the deduction of taxes that a shareholder may pay on Fund distributions or on gains resulting from redemption or sale of Fund shares.
The returns shown are based on net asset values calculated for shareholder transactions and may differ from the returns shown in the financial highlights, which reflect adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America. 
Nasdaq®, Nasdaq-100 Index®, Nasdaq 100® and NDX® are registered trademarks of Nasdaq, Inc. (which with its affiliates is referred to as the “Corporations”) and are licensed for use by the adviser. The Fund has not been passed on by the Corporations as to its legality or suitability. The Fund is not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE FUND.
December 31, 2022
J.P. Morgan Exchange-Traded Funds
17

JPMorgan ActiveBuilders U.S. Large Cap Equity ETF
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022  (Unaudited)
INVESTMENTS
SHARES
VALUE($)
Common Stocks — 99.4%
Aerospace & Defense — 1.7%
General Dynamics Corp.
   303
    75,177
Northrop Grumman Corp.
   269
   146,769
Raytheon Technologies Corp.
  1,520
   153,399
Textron, Inc.
   380
    26,904
 
 
402,249
Air Freight & Logistics — 0.9%
United Parcel Service, Inc., Class B
  1,193
   207,391
Airlines — 0.2%
Southwest Airlines Co.*
  1,119
    37,677
Auto Components — 0.0% ^
Magna International, Inc. (Canada)
   210
    11,798
Automobiles — 1.0%
Tesla, Inc.*
2,027
249,686
Banks — 4.2%
Bank of America Corp.
3,879
128,473
Citigroup, Inc.
817
36,953
Citizens Financial Group, Inc.
438
17,244
Fifth Third Bancorp
756
24,804
M&T Bank Corp.
170
24,660
PNC Financial Services Group, Inc. (The)
287
45,329
SVB Financial Group*
205
47,179
Truist Financial Corp.
6,049
260,288
US Bancorp
4,333
188,962
Wells Fargo & Co.
5,719
236,138
 
 
1,010,030
Beverages — 2.5%
Coca-Cola Co. (The)
6,508
413,974
Constellation Brands, Inc., Class A
135
31,286
Monster Beverage Corp.*
929
94,322
PepsiCo, Inc.
382
69,012
 
 
608,594
Biotechnology — 5.9%
AbbVie, Inc.
4,132
667,772
Alnylam Pharmaceuticals, Inc.*
112
26,617
Amgen, Inc.
513
134,734
Biogen, Inc.*
126
34,892
BioMarin Pharmaceutical, Inc.*
67
6,934
Neurocrine Biosciences, Inc.*
61
7,286
Regeneron Pharmaceuticals, Inc.*
494
356,416
INVESTMENTS
SHARES
VALUE($)
 
Biotechnology — continued
Seagen, Inc.*
   225
    28,915
Vertex Pharmaceuticals, Inc.*
   558
   161,139
 
 
1,424,705
Building Products — 1.0%
Masco Corp.
   357
    16,661
Trane Technologies plc
  1,289
   216,668
 
 
233,329
Capital Markets — 4.8%
Ameriprise Financial, Inc.
   374
   116,452
BlackRock, Inc.
   117
    82,910
Blackstone, Inc.
   456
    33,831
Charles Schwab Corp. (The)
2,109
175,595
CME Group, Inc.
182
30,605
Goldman Sachs Group, Inc. (The)
146
50,134
Intercontinental Exchange, Inc.
334
34,265
Morgan Stanley
3,970
337,529
MSCI, Inc.
52
24,189
Raymond James Financial, Inc.
182
19,447
S&P Global, Inc.
634
212,352
State Street Corp.
185
14,350
T. Rowe Price Group, Inc.
284
30,973
 
 
1,162,632
Chemicals — 2.0%
Air Products and Chemicals, Inc.
274
84,463
Axalta Coating Systems Ltd.*
2,294
58,428
DuPont de Nemours, Inc.
212
14,550
Eastman Chemical Co.
1,067
86,897
Linde plc (United Kingdom)
190
61,974
PPG Industries, Inc.
1,066
134,039
Sherwin-Williams Co. (The)
161
38,210
 
 
478,561
Commercial Services & Supplies — 0.1%
Cintas Corp.
22
9,936
Republic Services, Inc.
203
26,185
 
 
36,121
Communications Equipment — 0.1%
Motorola Solutions, Inc.
66
17,009
Construction Materials — 0.6%
Martin Marietta Materials, Inc.
35
11,829
Vulcan Materials Co.
763
133,609
 
 
145,438
SEE NOTES TO FINANCIAL STATEMENTS.
18
J.P. Morgan Exchange-Traded Funds
December 31, 2022

INVESTMENTS
SHARES
VALUE($)
Common Stocks — continued
Consumer Finance — 0.6%
American Express Co.
   742
   109,631
Capital One Financial Corp.
   490
    45,550
 
 
155,181
Containers & Packaging — 0.1%
Avery Dennison Corp.
    54
     9,774
Ball Corp.
   331
    16,927
 
 
26,701
Diversified Financial Services — 0.8%
Berkshire Hathaway, Inc., Class B*
   638
   197,078
Diversified Telecommunication Services — 0.4%
Verizon Communications, Inc.
  2,196
    86,522
Electric Utilities — 2.4%
Entergy Corp.
148
16,650
FirstEnergy Corp.
233
9,772
NextEra Energy, Inc.
4,553
380,631
PG&E Corp.*
3,775
61,381
Xcel Energy, Inc.
1,689
118,416
 
 
586,850
Electrical Equipment — 1.2%
Eaton Corp. plc
1,687
264,774
Rockwell Automation, Inc.
124
31,939
 
 
296,713
Electronic Equipment, Instruments & Components — 0.4%
Amphenol Corp., Class A
945
71,952
Corning, Inc.
226
7,219
TE Connectivity Ltd. (Switzerland)
83
9,528
 
 
88,699
Energy Equipment & Services — 0.7%
Baker Hughes Co.
5,586
164,955
Entertainment — 0.3%
Netflix, Inc.*
133
39,219
Walt Disney Co. (The)*
279
24,239
 
 
63,458
Equity Real Estate Investment Trusts (REITs) — 1.9%
AvalonBay Communities, Inc.
74
11,953
Camden Property Trust
65
7,272
Equinix, Inc.
33
21,616
Equity LifeStyle Properties, Inc.
188
12,145
Host Hotels & Resorts, Inc.
1,425
22,871
Prologis, Inc.
2,454
276,639
INVESTMENTS
SHARES
VALUE($)
 
Equity Real Estate Investment Trusts (REITs) — continued
SBA Communications Corp.
    129
    36,160
Sun Communities, Inc.
    119
    17,017
UDR, Inc.
    435
    16,848
Ventas, Inc.
    966
    43,518
 
 
466,039
Food & Staples Retailing — 0.4%
Costco Wholesale Corp.
    120
    54,780
Walmart, Inc.
    335
    47,500
 
 
102,280
Food Products — 0.3%
Hershey Co. (The)
     41
     9,495
Mondelez International, Inc., Class A
1,019
67,916
 
 
77,411
Health Care Equipment & Supplies — 2.6%
Abbott Laboratories
359
39,415
Baxter International, Inc.
479
24,415
Becton Dickinson and Co.
144
36,619
Boston Scientific Corp.*
4,961
229,545
Dexcom, Inc.*
298
33,745
Intuitive Surgical, Inc.*
596
158,149
Medtronic plc
868
67,461
Zimmer Biomet Holdings, Inc.
345
43,987
 
 
633,336
Health Care Providers & Services — 5.3%
Centene Corp.*
411
33,706
Cigna Corp.
188
62,292
CVS Health Corp.
956
89,090
Elevance Health, Inc.
181
92,848
HCA Healthcare, Inc.
421
101,023
Humana, Inc.
133
68,121
McKesson Corp.
465
174,431
UnitedHealth Group, Inc.
1,229
651,591
 
 
1,273,102
Hotels, Restaurants & Leisure — 2.4%
Airbnb, Inc., Class A*
139
11,885
Booking Holdings, Inc.*
38
76,581
Chipotle Mexican Grill, Inc.*
49
67,987
Expedia Group, Inc.*
168
14,717
Marriott International, Inc., Class A
916
136,383
McDonald's Corp.
972
256,151
Yum! Brands, Inc.
93
11,911
 
 
575,615
SEE NOTES TO FINANCIAL STATEMENTS.
December 31, 2022
J.P. Morgan Exchange-Traded Funds
19

JPMorgan ActiveBuilders U.S. Large Cap Equity ETF
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022  (Unaudited) (continued)
INVESTMENTS
SHARES
VALUE($)
Common Stocks — continued
Household Durables — 0.2%
Lennar Corp., Class A
    265
    23,982
Newell Brands, Inc.
    937
    12,256
Toll Brothers, Inc.
    143
     7,139
 
 
43,377
Household Products — 0.8%
Colgate-Palmolive Co.
    583
    45,935
Kimberly-Clark Corp.
    194
    26,335
Procter & Gamble Co. (The)
    827
   125,340
 
 
197,610
Industrial Conglomerates — 0.4%
Honeywell International, Inc.
    400
    85,720
Insurance — 1.7%
Aon plc, Class A
56
16,808
Chubb Ltd.
237
52,282
Globe Life, Inc.
101
12,176
Hartford Financial Services Group, Inc. (The)
617
46,787
Loews Corp.
348
20,299
Marsh & McLennan Cos., Inc.
131
21,678
MetLife, Inc.
538
38,935
Progressive Corp. (The)
941
122,057
Prudential Financial, Inc.
296
29,440
Travelers Cos., Inc. (The)
274
51,372
 
 
411,834
Interactive Media & Services — 4.1%
Alphabet, Inc., Class A*
5,706
503,441
Alphabet, Inc., Class C*
3,836
340,368
Meta Platforms, Inc., Class A*
1,274
153,313
 
 
997,122
Internet & Direct Marketing Retail — 2.4%
Amazon.com, Inc.*
6,534
548,856
Etsy, Inc.*
95
11,379
MercadoLibre, Inc. (Brazil)*
27
22,848
 
 
583,083
IT Services — 3.1%
Accenture plc, Class A
243
64,842
Automatic Data Processing, Inc.
322
76,913
Cognizant Technology Solutions Corp., Class A
696
39,804
FleetCor Technologies, Inc.*
134
24,613
International Business Machines Corp.
809
113,980
INVESTMENTS
SHARES
VALUE($)
 
IT Services — continued
Mastercard, Inc., Class A
    967
   336,255
Visa, Inc., Class A
    467
    97,024
 
 
753,431
Life Sciences Tools & Services — 0.6%
Danaher Corp.
    166
    44,060
Thermo Fisher Scientific, Inc.
    194
   106,834
 
 
150,894
Machinery — 2.4%
Deere & Co.
    918
   393,602
Dover Corp.
    560
    75,829
Otis Worldwide Corp.
    338
    26,469
Parker-Hannifin Corp.
254
73,914
 
 
569,814
Media — 0.7%
Charter Communications, Inc., Class A*
102
34,588
Comcast Corp., Class A
3,097
108,302
Trade Desk, Inc. (The), Class A*
488
21,877
 
 
164,767
Metals & Mining — 0.5%
Freeport-McMoRan, Inc.
2,689
102,182
Nucor Corp.
91
11,995
 
 
114,177
Multiline Retail — 0.9%
Dollar General Corp.
661
162,771
Target Corp.
314
46,799
 
 
209,570
Multi-Utilities — 0.8%
Ameren Corp.
219
19,474
CenterPoint Energy, Inc.
718
21,533
CMS Energy Corp.
777
49,207
Public Service Enterprise Group, Inc.
886
54,285
Sempra Energy
243
37,553
 
 
182,052
Oil, Gas & Consumable Fuels — 4.8%
Cheniere Energy, Inc.
251
37,640
Chevron Corp.
479
85,976
ConocoPhillips
4,006
472,708
Coterra Energy, Inc.
492
12,088
Diamondback Energy, Inc.
322
44,043
EOG Resources, Inc.
934
120,972
Exxon Mobil Corp.
2,365
260,859
SEE NOTES TO FINANCIAL STATEMENTS.
20
J.P. Morgan Exchange-Traded Funds
December 31, 2022

INVESTMENTS
SHARES
VALUE($)
Common Stocks — continued
Oil, Gas & Consumable Fuels — continued
Phillips 66
   119
    12,386
Pioneer Natural Resources Co.
   428
    97,751
Valero Energy Corp.
    80
    10,149
 
 
1,154,572
Personal Products — 0.1%
Estee Lauder Cos., Inc. (The), Class A
    71
    17,616
Pharmaceuticals — 3.9%
Bristol-Myers Squibb Co.
  4,740
   341,043
Eli Lilly & Co.
   822
   300,721
Johnson & Johnson
   859
   151,742
Merck & Co., Inc.
   656
    72,783
Pfizer, Inc.
1,211
62,052
 
 
928,341
Professional Services — 0.7%
Booz Allen Hamilton Holding Corp.
69
7,212
Equifax, Inc.
88
17,104
Leidos Holdings, Inc.
733
77,104
Verisk Analytics, Inc.
318
56,101
 
 
157,521
Road & Rail — 1.4%
CSX Corp.
1,841
57,034
Norfolk Southern Corp.
707
174,219
Uber Technologies, Inc.*
3,451
85,343
Union Pacific Corp.
127
26,298
 
 
342,894
Semiconductors & Semiconductor Equipment — 5.6%
Advanced Micro Devices, Inc.*
2,925
189,452
Analog Devices, Inc.
768
125,975
ASML Holding NV (Registered), NYRS (Netherlands)
164
89,610
Broadcom, Inc.
26
14,537
Enphase Energy, Inc.*
86
22,787
Lam Research Corp.
234
98,350
Microchip Technology, Inc.
301
21,145
Micron Technology, Inc.
139
6,947
NVIDIA Corp.
1,354
197,874
NXP Semiconductors NV (China)
2,029
320,643
QUALCOMM, Inc.
127
13,962
Teradyne, Inc.
758
66,211
Texas Instruments, Inc.
1,113
183,890
 
 
1,351,383
Software — 8.4%
Adobe, Inc.*
145
48,797
INVESTMENTS
SHARES
VALUE($)
 
Software — continued
Cadence Design Systems, Inc.*
    59
     9,478
DocuSign, Inc.*
   132
     7,315
Fortinet, Inc.*
   144
     7,040
Intuit, Inc.
   399
   155,299
Microsoft Corp.
  6,048
1,450,431
Oracle Corp.
  2,674
   218,573
Salesforce, Inc.*
   315
    41,766
Synopsys, Inc.*
   222
    70,882
Workday, Inc., Class A*
   141
    23,594
 
 
2,033,175
Specialty Retail — 4.1%
AutoNation, Inc.*
88
9,442
AutoZone, Inc.*
105
258,949
Best Buy Co., Inc.
330
26,469
Burlington Stores, Inc.*
64
12,977
Home Depot, Inc. (The)
309
97,601
Lowe's Cos., Inc.
1,766
351,858
O'Reilly Automotive, Inc.*
76
64,146
TJX Cos., Inc. (The)
2,083
165,807
 
 
987,249
Technology Hardware, Storage & Peripherals — 5.3%
Apple, Inc.
9,702
1,260,581
Seagate Technology Holdings plc
422
22,201
 
 
1,282,782
Textiles, Apparel & Luxury Goods — 0.9%
NIKE, Inc., Class B
1,485
173,760
Tapestry, Inc.
865
32,939
 
 
206,699
Tobacco — 0.5%
Altria Group, Inc.
516
23,586
Philip Morris International, Inc.
951
96,251
 
 
119,837
Wireless Telecommunication Services — 0.3%
T-Mobile US, Inc.*
456
63,840
Total Common Stocks
(Cost $25,502,902)
 
23,928,520
SEE NOTES TO FINANCIAL STATEMENTS.
December 31, 2022
J.P. Morgan Exchange-Traded Funds
21

JPMorgan ActiveBuilders U.S. Large Cap Equity ETF
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022  (Unaudited) (continued)
INVESTMENTS
SHARES
VALUE($)
Short-Term Investments — 0.4%
Investment Companies — 0.4%
JPMorgan U.S. Government Money Market Fund
Class IM Shares, 4.12%(a) (b)
(Cost $108,080)
108,080
   108,080
Total Investments — 99.8%
(Cost $25,610,982)
 
24,036,600
Other Assets Less Liabilities — 0.2%
 
38,420
NET ASSETS — 100.0%
 
24,075,020

Percentages indicated are based on net assets.
Abbreviations
 
NYRS
New York Registry Shares
^
Amount rounds to less than 0.1% of net assets.
*
Non-income producing security.
 
(a)
Investment in an affiliated fund, which is registered
under the Investment Company Act of 1940, as
amended, and is advised by J.P. Morgan Investment
Management Inc.
 
(b)
The rate shown is the current yield as of December
31, 2022.
 
Futures contracts outstanding as of December 31, 2022:
DESCRIPTION
NUMBER OF
CONTRACTS
EXPIRATION DATE
TRADING CURRENCY
NOTIONAL
AMOUNT ($)
VALUE AND
UNREALIZED
APPRECIATION
(DEPRECIATION) ($)
Long Contracts
 
 
 
 
 
Micro E-mini S&P 500 Index
6
03/17/2023
USD
115,830
(2,051)
Abbreviations
 
USD
United States Dollar
SEE NOTES TO FINANCIAL STATEMENTS.
22
J.P. Morgan Exchange-Traded Funds
December 31, 2022

JPMorgan Active Growth ETF
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022  (Unaudited)
INVESTMENTS
SHARES
VALUE($)
Common Stocks — 95.9%
Air Freight & Logistics — 0.7%
United Parcel Service, Inc., Class B
    5,414
    941,170
Automobiles — 1.6%
Tesla, Inc.*
   18,242
  2,247,050
Banks — 0.8%
First Republic Bank
    3,191
    388,951
SVB Financial Group*
    3,107
    715,045
 
 
1,103,996
Beverages — 2.5%
Coca-Cola Co. (The)
   29,946
  1,904,865
Constellation Brands, Inc., Class A
    3,118
    722,597
Monster Beverage Corp.*
    8,872
    900,774
 
 
3,528,236
Biotechnology — 8.1%
AbbVie, Inc.
15,807
2,554,569
Alnylam Pharmaceuticals, Inc.*
4,429
1,052,552
Amgen, Inc.
6,978
1,832,702
Exact Sciences Corp.*
12,301
609,023
Exelixis, Inc.*
17,889
286,940
Horizon Therapeutics plc*
10,303
1,172,481
Moderna, Inc.*
350
62,867
Natera, Inc.*
6,065
243,631
Regeneron Pharmaceuticals, Inc.*
4,379
3,159,405
Seagen, Inc.*
2,848
365,996
 
 
11,340,166
Building Products — 1.3%
Trane Technologies plc
10,885
1,829,660
Capital Markets — 4.5%
Blackstone, Inc.
14,419
1,069,745
Charles Schwab Corp. (The)
34,038
2,834,004
Morgan Stanley
14,993
1,274,705
MSCI, Inc.
613
285,149
S&P Global, Inc.
2,321
777,396
 
 
6,240,999
Chemicals — 0.3%
Sherwin-Williams Co. (The)
1,938
459,946
Commercial Services & Supplies — 0.6%
Copart, Inc.*
14,439
879,191
Communications Equipment — 0.2%
Arista Networks, Inc.*
2,418
293,424
Construction & Engineering — 1.0%
Quanta Services, Inc.
10,033
1,429,703
INVESTMENTS
SHARES
VALUE($)
 
Consumer Finance — 0.1%
Capital One Financial Corp.
    1,745
    162,215
Electrical Equipment — 1.3%
AMETEK, Inc.
    6,314
    882,192
Hubbell, Inc.
    2,379
    558,304
Rockwell Automation, Inc.
    1,490
    383,779
 
 
1,824,275
Electronic Equipment, Instruments & Components — 1.3%
Amphenol Corp., Class A
   11,413
    868,986
Keysight Technologies, Inc.*
    2,768
    473,522
Zebra Technologies Corp., Class A*
    1,591
    407,948
 
 
1,750,456
Energy Equipment & Services — 0.2%
Baker Hughes Co.
9,216
272,149
Entertainment — 0.1%
Take-Two Interactive Software, Inc.*
893
92,988
Health Care Equipment & Supplies — 2.7%
Cooper Cos., Inc. (The)
2,017
666,961
Dexcom, Inc.*
8,928
1,011,007
Insulet Corp.*
1,880
553,453
Intuitive Surgical, Inc.*
5,680
1,507,188
 
 
3,738,609
Health Care Providers & Services — 6.5%
Centene Corp.*
4,365
357,974
CVS Health Corp.
11,078
1,032,359
HCA Healthcare, Inc.
5,120
1,228,595
McKesson Corp.
7,211
2,704,990
UnitedHealth Group, Inc.
7,228
3,832,141
 
 
9,156,059
Hotels, Restaurants & Leisure — 2.7%
Airbnb, Inc., Class A*
1,601
136,885
Aramark
13,628
563,382
Booking Holdings, Inc.*
331
667,058
Chipotle Mexican Grill, Inc.*
326
452,322
Hilton Worldwide Holdings, Inc.
5,848
738,953
Marriott International, Inc., Class A
5,870
873,984
Royal Caribbean Cruises Ltd.*
6,065
299,793
 
 
3,732,377
Household Durables — 0.2%
Garmin Ltd.
3,569
329,383
Insurance — 0.6%
Progressive Corp. (The)
6,837
886,827
SEE NOTES TO FINANCIAL STATEMENTS.
December 31, 2022
J.P. Morgan Exchange-Traded Funds
23

JPMorgan Active Growth ETF
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022  (Unaudited) (continued)
INVESTMENTS
SHARES
VALUE($)
Common Stocks — continued
Interactive Media & Services — 4.0%
Alphabet, Inc., Class C*
   56,677
  5,028,950
Bumble, Inc., Class A*
   17,155
    361,113
Match Group, Inc.*
    1,050
     43,564
Meta Platforms, Inc., Class A*
      720
     86,645
Snap, Inc., Class A*
    1,704
     15,251
 
 
5,535,523
Internet & Direct Marketing Retail — 3.6%
Amazon.com, Inc.*
   54,512
  4,579,008
Etsy, Inc.*
    1,216
    145,652
MercadoLibre, Inc. (Brazil)*
      336
    284,337
 
 
5,008,997
IT Services — 4.5%
Automatic Data Processing, Inc.
4,024
961,173